Towards Healthcare Research & Consulting

Antimicrobial Urinary Catheters Companies, Corporate Milestones, Corporate Growth

Date : 17 March 2026

Top Vendors in the Antimicrobial Urinary Catheters Market & Their Offerings

Antimicrobial Urinary Catheters Market Companies are Becton, Dickinson and Company, Medline Industries, ConvaTec Group plc, Well Lead Medical Co., Ltd., Silq Technologies

Explore all your Antimicrobial Urinary Catheters Market insights and data in one place - Access the Dashboard Now

Company Offering 2026

Companies Headquarters Offerings
Becton, Dickinson and Company New Jersey, U.S. Develops infection-control Foley catheters that use antimicrobial coating technologies designed to limit bacterial attachment and reduce catheter-associated urinary tract infections in hospital settings.
Medline Industries Illinois, U.S. Supplies a wide range of urology products, including urinary catheters and infection-prevention solutions aimed at supporting safer catheterization and reducing the risk of CAUTIs. 
ConvaTec Group plc London, U.K. Offers continence care and urinary catheter products designed for patient comfort, infection management, and long-term bladder care in both clinical and home healthcare environments. 
Well Lead Medical Co., Ltd. Guangzhou, China Manufactures various urology devices such as Foley catheters and antimicrobial-treated urinary catheters intended to improve infection control during catheterization.
Silq Technologies Florida, U.S. Focuses on advanced catheter surface technologies that help prevent microbial buildup while improving lubrication and comfort for patients requiring catheterization
Halomine Inc. (AvantGuard) Indiana, U.S. Develops antimicrobial material technologies used in catheters to reduce microbial growth, biofilm formation, and infection risk during urinary drainage.

Supply Chain Analysis

R&D

  • Research and development in antimicrobial urinary catheters focuses on lowering catheter-associated urinary tract infections (CAUTIs), responsible for nearly 70–80% of hospital-acquired UTIs. Current innovations emphasize stronger and longer-lasting antimicrobial coatings for extended use. Companies are increasingly using materials such as silver, antibiotics, and hydrogels to improve infection control.
  • Key players: Becton, Dickinson and Company, Medline Industries, ConvaTec Group plc, Well Lead Medical, and Silq Technologies.

Clinical Trials

  • Clinical trials for antimicrobial urinary catheters mainly evaluate their ability to lower catheter-associated urinary tract infections (CAUTIs). These studies compare antimicrobial-coated catheters, such as silver-alloy, nitrofurazone, or antibiotic-treated devices, with standard catheters. Many trials report reduced bacterial growth, but results on lowering symptomatic infections remain inconsistent, particularly for long-term use. 
  • Key players: Becton, Dickinson and Company, Teleflex Incorporated, ConvaTec Group plc, Medline Industries, and Coloplast A/S.

Patient Support and Services

  • Patient support and service programs for antimicrobial urinary catheters focus on ensuring safe use and effective infection prevention. These services include proper catheter insertion, regular maintenance, patient and caregiver education, and timely removal to lower the risk of catheter-associated urinary tract infections (CAUTIs). Such support helps improve patient safety and treatment outcomes.
  • Key players: Becton, Dickinson and Company, Coloplast A/S, ConvaTec Group plc, Teleflex Incorporated, and Medline Industries.

Market Growth

The global antimicrobial urinary catheters market size was estimated at USD 1.24 billion in 2025 and is predicted to increase from USD 1.35 billion in 2026 to approximately USD 2.8 billion by 2035, expanding at a CAGR of 8.48% from 2026 to 2035.

Antimicrobial Urinary Catheters Market Size is USD 1.35 Billion 2026.

What are the Recent Developments in the Antimicrobial Urinary Catheters Market?

  • In May 2024, Laborie Medical Technologies reported encouraging two- and five-year clinical study outcomes for its Optilume BPH Catheter System, a minimally invasive treatment designed for benign prostatic hyperplasia. The results, shared at the American Urological Association Annual Meeting in San Antonio, Texas, showed lasting improvements in urinary flow and symptom relief, with a low need for retreatment and no negative effect on sexual function. These findings highlight the company’s ongoing focus on advancing urology treatments through research and innovation.
  • In April 2024, Medline Industries formed an exclusive distribution partnership with Consure Medical to supply the QiVi External Urinary Management System. The agreement is intended to strengthen Medline’s urinary care product range and support healthcare providers with improved solutions for managing urinary incontinence in clinical settings.

Get a free customized Antimicrobial Urinary Catheters Market sample with key stats, segments, and competitor insights: Download Free Sample Now